🇺🇸 FDA
Patent

US 6709830

Methods for modulating the activation of a lymphocyte expressed G protein coupled receptor involved in cell proliferation, autoimmunity and inflammation

expired A61KA61K38/00A61K39/00

Quick answer

US patent 6709830 (Methods for modulating the activation of a lymphocyte expressed G protein coupled receptor involved in cell proliferation, autoimmunity and inflammation) held by The Regents of the University of California expires Mon Mar 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/00, A61K39/00